A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2011
09/01/2011	WO2011003600A8 METHOD FOR THE PURIFICATION OF INTERFERON-β
09/01/2011	US20110214195 Methods For Treating Clinical Conditions Associated With Lipoprotein Lipase Activity
09/01/2011	US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway
09/01/2011	US20110213470 Methods for using a three-dimensional stromal tissue to promote angiogenesis
09/01/2011	US20110213328 Methods and Systems for Treatment of Neurological Diseases of the Central Nervous System
09/01/2011	US20110213193 Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier
09/01/2011	US20110213136 Antisense modulation of stearoyl-coa desaturase expression
09/01/2011	US20110213131 Method of Acylating a Peptide or Protein
09/01/2011	US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
09/01/2011	US20110213122 Obtaining cocoa extracts rich in bioactive peptides with ace and pep enzyme inhibitory activity
09/01/2011	US20110212903 Metal-binding compounds and uses therefor
09/01/2011	US20110212902 Metal-binding compounds and uses therefor
09/01/2011	US20110212901 Hyaluronic acid derivative and pharmaceutical composition thereof
09/01/2011	US20110212900 Method for prophylactic and/or therapeutic treatment of pain associated with hematopoietic cell transplantation
09/01/2011	US20110212899 Corneal Neuritogenesis Promoter Containing Pacap and Its Derivative
09/01/2011	US20110212898 Chimeric peptides for the regulation of gtpases
09/01/2011	US20110212897 Wnt3a for inhibition of scarring
09/01/2011	US20110212896 Peptides for the treatment of oxidative stress related disorders
09/01/2011	US20110212895 Treatment of Cognitive and Learning Impairment
09/01/2011	US20110212894 Decellularization method for scaffoldless tissue engineered articular cartilage or native cartilage tissue
09/01/2011	US20110212893 Nell-1 enhanced bone mineralization
09/01/2011	US20110212892 Agent for treatment of diabetes
09/01/2011	US20110212891 Azepinone derivatives
09/01/2011	US20110212890 Metastin derivative and use thereof
09/01/2011	US20110212889 Use of leptin for the treatment of fatty liver diseases and conditions
09/01/2011	US20110212888 Diet and methods for improving learning capacity, mood and behavior in mammals
09/01/2011	US20110212887 Methods of treating obesity using enterostatin
09/01/2011	US20110212886 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
09/01/2011	US20110212885 Ophthalmic and contact lens solutions containing peptides as preservative
09/01/2011	US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/01/2011	US20110212883 Radical scavenger and active oxygen eliminating agent
09/01/2011	US20110212882 Uses of kappa opioid synthetic peptide amides
09/01/2011	US20110212881 Aleurone as a prebiotic fiber for improved intestinal health
09/01/2011	US20110212529 Muscle-specific expression vectors
09/01/2011	US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
09/01/2011	US20110212168 Composition for targeting dendritic cells
09/01/2011	US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/01/2011	US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions
09/01/2011	US20110212161 Treatment skin disorders
09/01/2011	US20110212160 Configurable microscopic medical payload delivery device to deliver nuclear signaling proteins to specific cells to manage diabetes mellitus and genetic deficiency disorders
09/01/2011	US20110212157 Dermal delivery
09/01/2011	US20110212155 Flexible, Compressed Intravaginal Rings, Methods of Making and Using the Same, and Apparatus for Making the Same
09/01/2011	US20110212139 High-density lipoprotein coated medical devices
09/01/2011	US20110212138 Sustained release formulations using non-aqueous carriers
09/01/2011	US20110212136 Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury
09/01/2011	US20110212115 Melk epitope peptides and vaccines containing the same
09/01/2011	US20110212108 Neuregulin/erbb signaling and integrin
09/01/2011	US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
09/01/2011	US20110212105 Method to block the infection by flaviviruses, molecules and uses
09/01/2011	US20110212099 Methods of modulating il-22 and il-17
09/01/2011	US20110212085 Lung cancer disease targets and uses thereof
09/01/2011	US20110212083 Role of soluble upar in the pathogenesis of proteinuric kidney disease
09/01/2011	US20110212081 Krüppel-like factors and fat regulation
09/01/2011	US20110212079 Adaptive biochemical signatures
09/01/2011	US20110212075 Screening method for polymorphic markers in htra1 gene in neurodegenerative disorders
09/01/2011	US20110212074 Myeloid colony stimulating factor and uses thereof
09/01/2011	US20110212073 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
09/01/2011	US20110212072 Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction
09/01/2011	US20110212057 Cycloundecadepsipeptide compounds and use of said compounds as a medicament
09/01/2011	US20110212056 Combination therapy for the treatment of liver diseases
09/01/2011	US20110212055 Neurodegenerative disorders
09/01/2011	US20110212054 Thrombopoietin mimetics
09/01/2011	US20110212053 Phosphatidylinositol 3 kinase inhibitors
09/01/2011	US20110212052 Methods and compositions of treating and preventing autoimmune diseases
09/01/2011	US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof
09/01/2011	US20110210460 Process for producing pellets for pharmaceutical compositions
09/01/2011	CA2791122A1 Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios
09/01/2011	CA2791058A1 Methods for inhibiting necrosis
09/01/2011	CA2790996A1 Therapeutic agent for eating disorders
09/01/2011	CA2790918A1 Pharmaceutical or neutraceutical formulation
09/01/2011	CA2790823A1 Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy
09/01/2011	CA2790818A1 Modulation of cytokine-induced chronic inflammatory responses
09/01/2011	CA2790786A1 Process for production and purification of recombinant lysosomal alpha-mannosidase
09/01/2011	CA2789886A1 Stable compositions of factor ix
08/2011
08/31/2011	EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions
08/31/2011	EP2361988A1 Molecular marker for cancer stem cell
08/31/2011	EP2361982A1 Human gene encoding ubiquitin conjugating enzyme
08/31/2011	EP2361981A1 RNA sequence-specific mediators of RNA interference
08/31/2011	EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer
08/31/2011	EP2361930A2 Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
08/31/2011	EP2361925A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/31/2011	EP2361923A2 Oligoribonucleotides and ribonucleases for cleaving RNA
08/31/2011	EP2361922A1 Intermediate to HCV-Nucleoside Inhibitors
08/31/2011	EP2361631A1 Treatment of alpha-galactosidase a deficiency
08/31/2011	EP2361630A1 Implantable drug delivery device comprising particles and an osmotic pump
08/31/2011	EP2361629A1 Prevention and treatment of synucleinopathic disease
08/31/2011	EP2361623A1 Composition comprising a polyphenol salt and corresponding use
08/31/2011	EP2361621A1 Human carbamyl phosphate synthetase I polymorphism and diagnostic and therapeutic methods relating thereto
08/31/2011	EP2361613A1 Stabilized compositions of proteins having a free thiol moiety
08/31/2011	EP2361258A1 A nonapeptide with anti-tumour activity
08/31/2011	EP2361119A1 Fibroblast growth factor-9 promotes hair follicle regeneration after wounding
08/31/2011	EP2361097A2 Na/k-atpase-derived peptide src inhibitors and ouabain antagonists and uses thereof
08/31/2011	EP2361093A2 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
08/31/2011	EP2361086A1 Treatment of oncological diseases
08/31/2011	EP2187915B1 Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases
08/31/2011	EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME
08/31/2011	EP1523325B1 Methods and compositions for treating polycystic ovary syndrome
08/31/2011	EP1521754B1 Viral inhibitors
08/31/2011	EP1506000B9 Heterocyclicsulfonamide hepatitis c virus inhibitors
08/31/2011	EP1474505B1 Noninvasive genetic immunization by topical application of bacterial vectors

1 ... 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 ... 3163